98%
921
2 minutes
20
Purpose: Dry eye disease with ocular surface inflammation leads to corneal epithelial cell damage. This study aims to investigate the role of activating transcription factor 3 (ATF3) in hyperosmotic stress (HS)-induced damage in human corneal epithelial (HCE) cells and to identify new targets for dry eye disease treatment.
Methods: HCE cells were treated with isotonic or hypertonic (312 and 500 mOsM) culture media for 24 hours and added by 94 mM of NaCl to achieve hyperosmotic conditions. After siRNA-ATF3 transfection, the expression of ATF3, LncRNA nuclear-enriched abundant transcript 1 (NEAT1), human antigen R (HuR), and toll-like receptor 4 (TLR4) were detected using qRT-PCR and western blot assays. Cell proliferation was analyzed by the CCK-8 assay. LDH, ROS, TNF-α, IL-1β, and IL-6 levels were measured. Cell apoptosis was measured by flow cytometry. ATF3 enrichment on the NEAT1 promoter was analyzed. The binding of ATF3 to the NEAT1 promoter and HuR to NEAT1 and TLR4 was analyzed. TLR4 mRNA stability was measured. Overexpression of NEAT1 or TLR4 combined with ATF3 knockdown was performed to verify the mechanism.
Results: HS induced LDH release, ROS production, apoptosis, and inflammation in HCE cells and upregulated ATF3 expression. Knockdown of ATF3 alleviated above cell damage. ATF3 promoted NEAT1 expression, and NEAT1 enhanced the stability of TLR4 mRNA by binding to HuR. Overexpression of NEAT1 or TLR4 partially reversed the protective effect of ATF3 knockdown on HS-induced HCE cell damage.
Conclusions: ATF3 promotes HS-induced damage in HCE cells by increasing TLR4 expression through upregulating NEAT1 expression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/ICO.0000000000003945 | DOI Listing |
Exp Eye Res
September 2025
Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; BEGIKER Ophthalmology Research Group, Biobizkaia Health Research Institute, 48903, Barakaldo, Spain. Electronic address:
The objective of this study was to develop a reliable, cost-effective, and rapid in vitro model employing real-time PCR to assess inflammatory responses in hydrogel-based systems, and to comparatively evaluate the anti-inflammatory efficacy of human serum (HS), serum derived from plasma rich in growth factors (sPRGF), and human amniotic membrane extracts (HAMe) incorporated into gelatin-based hydrogels. An in vitro model of corneal inflammation was established by quantifying IL-1β expression via qPCR in TNFα-stimulated SV-40 immortalised human corneal epithelial (HCE) cells. Hydrogels functionalised with HS, sPRGF, or HAMe sourced from proximal, medial, distal, or pooled amniotic regions were evaluated for their anti-inflammatory potential.
View Article and Find Full Text PDFTher Deliv
August 2025
Pharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India.
Aim: Glaucoma is associated with abnormal IOP elevation leading to irreversible blindness. In this study, we explore the therapeutic potential of thymoquinone in combination with travoprost to enhance the treatment efficacy of glaucoma.
Method: Thymoquinone-travoprost co-loaded liposomes (LP-TP-TQ) were formulated using thin-film hydration technique and optimized using BBD.
PLoS One
August 2025
Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Fungal keratitis (FK) is a sight-threatening infectious disease that can result in blindness if not appropriately treated. Although keratitis associated with filamentous fungi was rarely reported in the past, the incidence of fungal keratitis due to contact lens usage has increased. The clinical manifestations of fungal keratitis often resemble those of other corneal infections, potentially delaying accurate diagnosis and treatment.
View Article and Find Full Text PDFMolecules
July 2025
CNR-Institute of Biomolecular Chemistry, Via Paolo Gaifami 18, 95126 Catania, Italy.
Nepafenac is an anti-inflammatory drug used in ophthalmology, marketed as a suspension due to its low aqueous solubility. A solution formulation could provide better bioavailability than suspension and facilitate single unit doses, avoiding the use of preservatives which are required to maintain sterility in multidose packaging. In this study, solubilization of nepafenac was achieved in the presence of randomly methylated β-cyclodextrin (RAMEB) and the actual complexation was assessed by NMR and phase-solubility studies.
View Article and Find Full Text PDFPurpose: Dry eye disease with ocular surface inflammation leads to corneal epithelial cell damage. This study aims to investigate the role of activating transcription factor 3 (ATF3) in hyperosmotic stress (HS)-induced damage in human corneal epithelial (HCE) cells and to identify new targets for dry eye disease treatment.
Methods: HCE cells were treated with isotonic or hypertonic (312 and 500 mOsM) culture media for 24 hours and added by 94 mM of NaCl to achieve hyperosmotic conditions.